The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2019 | Deep responses induced by chemo-free combos in CLL
Lydia Scarfò
• 7 Dec 2019
Lydia Scarfò, MD, Vita-Salute San Raffaele University, Milan, Italy, shares the key updates in chronic lymphocytic leukemia (CLL) from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Dr. Scarfò highlights the use of combination chemo-free regimens in the majority of CLL patients.
